The Pulmonary Hypertension Association (PHA) urges people with pulmonary hypertension (PH), health care providers and oxygen suppliers to use new Centers for Medicare and Medicaid Services (CMS) guidelines during the COVID-19 pandemic. The latest rules, issued March 30, waive in-person testing and signature requirements for supplemental oxygen deliveries.
PHA is proud to be among a group of organizations that led the way in advocating for CMS to make effective changes in supplemental oxygen protocols.
The group requested through a jointly signed letter that, given the current global health pandemic, CMS waive all in-person testing requirements for patients receiving supplemental oxygen for the first time, as well as for patients who require recertification for oxygen prescriptions. The groups also urged CMS to waive the requirement for signature at delivery of supplemental oxygen.
According to CMS, the in-person testing and signature requirement waivers will remain effective throughout the COVID-19 public health emergency. That will give health care professionals the utmost flexibility to care for patients.
For more information or to contact PHA’s Advocacy and Treatment Access Department, email us or call 301-565-3004 x749.